The Federal Court has upheld Novartis’ appeal of a ruling revoking its patent for an oral form of multiple sclerosis drug Gilenya, after Australian generic […]
Subscribe for instant access to all Lawyerly content.
Already a subscriber?
Want to test drive Lawyerly? Contact us to take a free trial.